Related Experiment Video
Updated: Aug 8, 2026

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
Published on: April 1, 2015
Beta 2-microglobulin is not a bone cell mitogen
J C Jennings1, S Mohan, D J Baylink
1Department of Medicine, Loma Linda University School of Medicine, California.
Abstract:
During the purification of skeletal growth factor/insulin-like growth factor-II and transforming growth factor-beta (TGF beta) from EDTA extracts of bovine bone matrix significant mitogenic activity for cultured osteoblast (Ob)-like cells eluted in fractions that contained a nearly homogeneous peptide with a mol wt of about 14,000. This peptide has been purified to apparent homogeneity and identified as bovine beta 2-microglobulin (beta 2M) by amino-terminal amino acid sequencing. During the final purification of beta 2M by CN reverse phase HPLC the mitogenic activity for bone cells separated from the beta 2M protein peak. In spite of this the apparently homogeneous beta 2M preparation retained some mitogenic activity. The ED50 of the bone-derived beta 2M (4,890 +/- 462 ng/ml) was several orders of magnitude (2 x 10(3) to 1.4 x 10(5) times) greater than the ED50 of simultaneously assayed purified growth factors and was no different from the ED50 of the crude EDTA matrix extract (3,350 +/- 890 ng/ml). The beta 2M accounted for less than 0.002% of the total mitogenic activity for Ob-like cells present in the extracted matrix proteins. The following lines of evidence suggest that the mitogenic activity of bone matrix-derived beta 2M (BMD-beta 2M) is due to contamination of the BMD-beta 2M with TGF beta rather than an intrinsic property of beta 2M: 1) the coelution of TGF beta through four successive purification procedures and purification of TGF beta from adjoining fractions from C4 reverse phase HPLC; 2) the abolition of biological activity of BMD-beta 2M and TGF beta with reducing agents; 3) the lack of additive stimulation of [3H] methylthymidine incorporation into bone cells when beta 2M was added to maximally active concentrations of purified TGF beta; 4) the reduction of mitogenic activity when the BMD-beta 2M was incubated with anti-TGF beta; and 5) the inhibition of mink lung epithelial proliferation by the beta 2M preparation. Based on these findings we conclude that although beta 2M is present in bovine bone matrix extracts, it is not a mitogen for Ob-like cells.
Insights
Bovine beta 2-microglobulin (beta 2M) isolated from bone matrix extracts showed mitogenic activity for osteoblast-like cells. However, this activity was attributed to transforming growth factor-beta (TGF beta) contamination, not an intrinsic property of beta 2M.
Area of Science:
- Biochemistry
- Cell Biology
- Bone Biology
Background:
- Bone matrix contains various growth factors influencing osteoblast proliferation.
- Beta 2-microglobulin (beta 2M) is a protein found in various biological fluids and tissues.
- Previous studies suggested potential mitogenic roles for matrix components.
Purpose of the Study:
- To purify and identify a mitogenic peptide from bovine bone matrix extracts.
- To determine if beta 2-microglobulin (beta 2M) possesses intrinsic mitogenic activity for osteoblast-like cells.
- To investigate the source of mitogenic activity observed in beta 2M preparations.
Main Methods:
- Purification of peptides from EDTA extracts of bovine bone matrix using chromatography.
- Amino-terminal amino acid sequencing to identify the purified peptide.
- Mitogenic assays using cultured osteoblast-like cells and [3H] methylthymidine incorporation.
- Characterization of biological activity using reducing agents and antibodies.
Main Results:
- A peptide identified as bovine beta 2-microglobulin (beta 2M) was purified and showed mitogenic activity.
- The mitogenic activity of beta 2M was significantly lower than purified growth factors and comparable to crude extracts.
- Evidence strongly suggested that the observed mitogenic activity was due to transforming growth factor-beta (TGF beta) contamination.
- Biological activity was abolished by reducing agents and neutralized by anti-TGF beta antibodies.
Conclusions:
- Beta 2-microglobulin (beta 2M) present in bovine bone matrix extracts is not intrinsically mitogenic for osteoblast-like cells.
- The mitogenic activity associated with purified beta 2M preparations is attributable to contaminating transforming growth factor-beta (TGF beta).
- This study clarifies the role of beta 2M in bone cell proliferation, distinguishing it from potent mitogens like TGF beta.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation

